Package Leaflet: Information for the User
Dutasteride/Tamsulosin Krka 0.5 mg/0.4 mg Hard Capsules EFG
dutasteride/hydrochloride of tamsulosin
Read this leaflet carefully before you start to take this medicine because it contains important information for you.
Dutasterida/Tamsulosina Krka is used in men to treat an enlarged prostate(benign prostatic hyperplasia)- a non-cancerous growth of the prostate caused by excessive production of a hormone called dihydrotestosterone.
Dutasterida/Tamsulosina Krkais a combination of two different medications called dutasteride and tamsulosin. Dutasteride belongs to a group of medications called5-alpha reductase inhibitorsand tamsulosin belongs to a group of medications calledalpha blockers.
As the prostate grows in size, it may produce urinary problems such as difficulty in urinating and a need to urinate more frequently. It may also cause the urine stream to be smaller and weaker. If left untreated, there is a risk of complete blockage of the urine flow(acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or remove it.
Dutasteride reduces the production of the hormone called dihydrotestosterone, which helps to reduce the size of the prostate and alleviate symptoms. This reduces the risk of acute urinary retention and the need for surgery. Tamsulosin acts by relaxing the muscles of the prostate, making urination easier and rapidly improving symptoms.
Do not takeDutasteride/Tamsulosin Krka
-if you are a woman (because this medication is only for men).
-if you are a child or adolescent under 18 years of age.
-if you are allergic to dutasteride, to other 5-alpha reductase enzyme inhibitors, to tamsulosin, to soy, peanuts, orto any of the other components of this medication(listed in section 6).
-if you have low blood pressure, which makes you feel dizzy, lightheaded, or faint (orthostatic hypotension).
-if you have a severe liver disease.
If you think you have any of these conditions, do not take this medication until you have consulted with your doctor.
Warnings and precautions
Consult your doctor before starting to take Dutasteride/Tamsulosin
Consult your doctor or pharmacist if you have any doubts related to taking Dutasteride/Tamsulosin
Taking Dutasteride/Tamsulosin Krka with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Do not take Dutasteride/Tamsulosin with these medications:
Do not take Dutasteride/Tamsulosin with these medications:
Certain medications may interact with Dutasteride/Tamsulosin, which may cause you to experience adverse effects. Some of these medications are:
Inform your doctor if you are taking any of these medications.
Taking Dutasteride/Tamsulosin Krka with food
You should takeDutasteride/Tamsulosin30 minutes after the same meal every day.
Pregnancy, breastfeeding, and fertility
Women should not takeDutasteride/Tamsulosin
Pregnant women (or those who may be pregnant) should avoid contact with broken capsules. Dutasteride is absorbed through the skin and may affect the normal development of the male fetus. This risk is especially important in the first 16 weeks of pregnancy.
Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking Dutasteride/Tamsulosin.If your partner is pregnant or may be pregnant, you should avoid exposing her to your semen.
Dutasteride/Tamsulosin has been shown to decrease sperm count, semen volume, and sperm motility. This may reduce your fertility.
Consult your doctor if a pregnant woman has been in contact with Dutasteride/Tamsulosin.
Driving and operating machinery
Some people may experience dizziness during treatment withDutasteride/Tamsulosin, which may affect their ability to drive or operate machinery safely.
Do not drive or operate machinery if you are affected in this way.
Dutasteride/Tamsulosin Krka contains lecithin from soy, propylene glycol, and sodium
This medication contains lecithin from soy, which may contain soy oil. It should not be used in cases of allergy to peanuts or soy.
This medication contains less than 23 mg of sodium (1 mmol) per capsule; that is, it is essentially “sodium-free”.
This medication contains 299 mg of propylene glycol in each capsule.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If you do not take it regularly, the control of your PSA levels may be affected. In case of doubt, consult your doctor or pharmacist again.
What dose should you take
The recommended dose is one capsule once a day, 30 minutes after the same meal every day.
How to take it
The capsules should be swallowed whole, with water. Do not chew or break the capsules. Contact with the contents of the capsules may irritate your mouth or throat.
If you take more Dutasterida/Tamsulosina Krka than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Dutasterida/Tamsulosina Krka
Do not take a double dose to compensate for the missed doses. Take the next dose at the usual time.
If you interrupt the treatment with Dutasterida/Tamsulosina Krka
Do not interrupt the treatment with Dutasterida/Tamsulosina Krka without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Allergic reaction
The signs of an allergic reaction may include:
Contact your doctor immediately if you experience any of these symptoms and stop taking Dutasteride/Tamsulosin.
Dizziness, lightheadedness, and fainting
Dutasteride/tamsulosin may cause dizziness, lightheadedness, and, in rare cases, fainting. You should be careful when getting up quickly after lying down or sitting, especially if you have to get up during the night, until you know how this medicine affects you. If you feel dizzy or experience lightheadedness during treatment, sit or lie down until these symptoms have disappeared.
Severe skin reactions
The signs of severe skin reactions may include:
Contact your doctor immediately if you have these symptoms and stop using Dutasteride/Tamsulosin.
Common side effects
These may affect up to 1 in 10 men taking dutasteride/tamsulosin:
*In a small number of people, some of these adverse events may continue after stopping dutasteride/tamsulosin.
These may affect up to 1 in 100 men:
Rare side effects
These may affect up to 1 in 1,000 men:
Very rare side effects
These may affect up to 1 in 10,000 men:
Other side effects
Other side effects have been reported in a reduced number ofmen,but their exact frequency is unknown (the frequency cannot be estimated from the available data):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the bottle after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need.By doing so, you will help protect the environment.
Composition of Dutasterida/Tamsulosina Krka
The active ingredients are dutasteride and tamsulosin hydrochloride. Each hard capsule contains 0.5 mg of dutasteride and 0.4 mg of tamsulosin hydrochloride (equivalent to 0.367 mg of tamsulosin). The other components are:
Hard capsule coating:
Iron oxide black (E172)
Iron oxide red (E172)
Titanium dioxide (E171)
Iron oxide yellow (E172)
Gelatin
Content of the soft gelatin capsule of dutasteride:
Propylene glycol monocaprylate, type II
Butylhydroxytoluene (E321)
Coating of the soft gelatin capsule:
Gelatin
Glycerol
Titanium dioxide (E171)
Medium-chain triglycerides
Lecithin (may contain soy oil)
Tamsulosin pellets:
Copolymer of methyl acrylate and ethyl acrylate (1:1) dispersion 30 percent (contains sodium lauryl sulfate, polysorbate 80)
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Colloidal hydrated silica
Calcium stearate
Black ink:
Shellac (E904)
Iron oxide black (E172)
Propylene glycol (E1520)
Concentrated ammonia solution (E527)
Potassium hydroxide (E525)
See section 2 “Dutasterida/Tamsulosina Krka contains soy lecithin, propylene glycol, and sodium”.
Appearance of the product and contents of the package
This medicine is presented inhard, oblong capsules, approximately 24.2 mm x 7.7 mm, with a brown body and beige cap printed with C001 in black ink..
Each hard capsule contains modified-release pellets of tamsulosin hydrochloride and a soft gelatin capsule of dutasteride.
It is available in packages of 7, 30, and 90 capsules.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
KRKA, d.d., Novo mesto
Šmarješka cesta 6,
8501 Novo mesto, Slovenia
Manufacturer responsible:
LEÓN FARMA, S.A.,
C/La Vallina, s/n, Industrial Estate Navatejera,
24193 Villaquilambre, León, Spain
KRKA, d.d., Novo mesto
Šmarješkacesta 6,
8501 Novo mesto, Slovenia
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L.,
Calle de Anabel Segura 10,
28108 Alcobendas, Madrid, Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Member state | Medicine name |
Denmark | Dutasterid/Tamsulosin Krka |
Belgium | Dutasterid/Tamsulosin KRKA 0.5 mg/0.4 mg hard capsules |
Czech Republic | Twinpros |
Germany | Dutastam 0.5 mg/0.4 mg Hartkapseln |
Estonia | Twinpros |
Spain | Dutasterida/Tamsulosina Krka 0.5 mg/0.4 mg hard capsules EFG |
Finland | Dutasterid/Tamsulosin KRKA 0.5 mg/0.4 mg kapseli, kova |
Hungary | Twinpros 0.5 mg/0.4 mg kemény kapszula |
Croatia | Twinpros 0.5 mg/0.4 mg tvrde kapsule |
Iceland | Dutasterid/Tamsulosin KRKA 0.5 mg/0.4 mg hörð hylki |
Lithuania | Twinpros 0.5 mg/0.4 mg kietosios kapsules |
Latvia | Twinpros 0.5 mg/0.4 mg cietas kapsulas |
Poland | Twinpros |
Portugal | Dutasterida/Tamsulosina KRKA 0.5 mg/0.4 mg cápsulas |
Romania | Twinpros 0.5 mg/0.4 mg capsule |
Slovakia | Twinpros 0.5 mg/0.4 mg tvrdé kapsuly |
Slovenia | Twinpros 0.5 mg/0.4 mg trde kapsule |
Last review date of this leaflet:February 2025
For detailed and updated information about this medicine, visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.